HONYAKU Center Inc.
2483・Standard Market・Services
Business
Honyaku Center Inc., founded in 1986, is a specialized translation company whose core business is high-quality translation services focused on four fields: patents, pharmaceuticals, industrial localization, and finance/law. With 5 consolidated subsidiaries and 1 affiliate, the company operates its translation business (net sales of ¥8,096 million) as its flagship, alongside language-specialized staffing (¥1,123 million), in-house corporate and international conference interpreting (¥1,323 million), and convention services, language education, and support for overseas patent filings, etc. (¥328 million). Its major clients are large enterprises such as patent firms, pharmaceutical companies, automakers, and financial institutions, and the company is listed on the Standard Market of the Tokyo Stock Exchange.
Business Model
The company adopts a fabless-type model in which, after receiving orders from clients, it selects registered translators/interpreters, commissions the translation/interpretation work, performs in-house quality control, and delivers the finished product. Procurement costs are centered on outsourcing fees paid to registered staff, resulting in a structure that enables the provision of highly specialized services while keeping fixed costs in check. In the staffing (dispatch) business, the company secures recurring revenue by dispatching translators/interpreters to client companies, while the interpretation business builds up sales through a combination of spot and ongoing projects.
Company Strengths
Expanding from its founding in 1986 as a specialist in medical translation into the patent, industrial, and financial fields, the company has provided specialized translation services for approximately 40 years. In FY2026 (ending March 2026), translation business revenue remained at ¥8,096 million, and the company has secured continued business with major clients such as patent offices, pharmaceutical companies, and financial institutions. Its specialist brand, backed by decades of track record, constitutes an entry barrier that competitors find difficult to replicate in a short period.
The company has built an integrated comprehensive language services structure encompassing translation, staffing, interpretation, language education, and support for foreign patent filings. In FY2026 (ending March 2026), the interpretation business posted revenue of ¥1,323 million (up 11.4% year on year), setting a record high for the third consecutive period, while the language education school (ISS Institute) serves as a talent supply function for the staffing and interpretation businesses, demonstrating functioning intra-group synergies.
As of the end of FY2026 (ending March 2026), the company held cash and cash equivalents of ¥4,409 million, while interest-bearing debt stood at only ¥17 million, maintaining a virtually debt-free management stance. Total net assets stood at ¥7,023 million, with an equity ratio at a high level, giving the company a financial foundation capable of funding system investments under its medium-term management plan (core system costs of ¥287,026 thousand) and future M&A with internal funds.
ENVALITH's Perspective
Performance Trend
Revenue expanded from ¥10,337 million in FY2022 to ¥11,304 million in FY2024, before contracting for two consecutive periods to ¥11,210 million in FY2025 and ¥10,871 million in FY2026. Operating profit, which peaked at ¥929 million in FY2023, has continued to decline, falling to ¥705 million in FY2026, below even the FY2022 level of ¥811 million. As an external factor, uncertainty surrounding US trade policy led automotive-related clients to curb orders, resulting in sharp revenue declines in the Industrial & Localization segment (down 15.3% year on year) and the Financial & Legal segment (down 12.2% year on year). Selling, general and administrative expenses rose slightly to ¥4,448 million, failing to offset the decline in gross profit. Net income of ¥462 million fell sharply by 36.1% year on year, affected by the year-on-year absence of extraordinary gains recorded in the prior period (gain on sale of subsidiary shares and relocation compensation totaling ¥195 million) as well as the recognition of a ¥37 million impairment loss. For FY2027 (ending March 2027), the company forecasts a recovery to revenue of ¥11,300 million and operating profit of ¥750 million.
Growth Strategy
Mid-term management plan promoting a recovery in performance through competitiveness enhancement via AI and data utilization, and expansion of the Interpretation Business and new services
Promoting service provision utilizing natural language processing technologies such as CAT, MT, and LLM, and sales/marketing based on data analysis. As a core initiative of the mid-term management plan (FY2026 through FY2028, ending March 2028), the company aims to strengthen competitiveness through productivity improvement and new service development enabled by AI. In FY2026 (ending March 2026), software in progress surged to ¥306 million, reflecting a full-scale ramp-up of system investment.
Promoting proposals for high-value-added services combining interpretation work with related services, aiming to deepen relationships with client companies. In FY2026 (ending March 2026), the business renewed its record high for the third consecutive period (¥1,323 million), driven by continued orders from existing clients and the acquisition of new global conference and large-scale spot projects.
Began offering new services targeting timely disclosure information in the financial and legal fields, leading to an increase in orders for IR-related documents. The company aims to expand its customer share through the establishment of long-term, stable relationships with client companies. In the financial and legal field in FY2026 (ending March 2026), although the new service had a positive effect, overall performance in the segment declined 12.2% year on year due to a decrease in orders for legal-related documents and a rebound decline from large-scale projects in the previous period.
Citrus Japan Co., Ltd. was made a subsidiary during the fiscal year under review and added to the scope of consolidation. In addition, FIPAS Co., Ltd. was absorbed through merger effective October 1, 2025, reorganizing the group structure. The company intends to continue strengthening its business foundation and expanding into new areas through M&A. Cash flow used in investing activities expanded significantly to ¥943 million (compared with ¥195 million in the previous period).
Last updated: July 19, 2026